Subscribe To

Price Alert Latest News Economic Calendar News

ICCM / IceCure Medical Ltd (ICCM) Q3 2022 Earnings Call Transcript

IceCure Medical Ltd (NASDAQ:ICCM ) Q3 2022 Results Conference Call December 2, 2022 8:00 AM ET Company Participants Eyal Shamir - Chief Executive Officer Ronen Tsimerman - Chief Financial Officer Hania Bednarski - Oncoplastic Breast Surgeon and Cryoablation Specialist Conference Call Participants Ben Haynor - Alliance Global Partners Anthony Vendetti - Maxim Group Kemp Dolliver - Brookline Capital Markets Operator Welcome to IceCure's Conference Call on the Financial Results for the Nine Months Ended September 30, 2022, and update on recent operational highlights. Management will provide an overview of IceCure's financial results as well as clinical, commercial and operational highlights. Read More

Demo Live Account See Partner Details

Content Topics

Icecure

Medical

ICCM

2022

Earnings

Call

Transcript

iccm

Stock

Posted: Dec 5 2022, 10:20

Author Name: Seeking Alpha

ICCM News

By Seeking Alpha
August 14, 2023

IceCure Medical Ltd (ICCM) Q2 2023 Earnings Call Transcript

IceCure Medical Ltd (NASDAQ:ICCM ) Q2 2023 Earnings Conference Call August 14, 2023 10:00 AM ET Company Participants Todd Kehrli - EVC Group, Investor

By Seeking Alpha
May 22, 2023

IceCure Medical Ltd (ICCM) Q1 2023 Earnings Call Transcript

IceCure Medical Ltd (NASDAQ:ICCM ) Q1 2023 Earnings Conference Call May 22, 2023 10:00 AM ET Company Participants Todd Kehrli - EVC Group, IR Eyal Sha

By Seeking Alpha
March 29, 2023

IceCure Medical Ltd (ICCM) Q4 2022 Earnings Call Transcript

IceCure Medical Ltd (NASDAQ:ICCM ) Q4 2023 Earnings Conference Call March 29, 2023 10:00 AM ET Company Participants Eyal Shamir - CEO Ronen Tsimerman

By Proactive Investors
December 20, 2022

IceCure Medical rockets higher on positive study data showing effectiveness of ProSense kidney tumor treatment

Shares of IceCure Medical Ltd (NASDAQ:ICCM) went on a tear after a study revealed its ProSense treatment was safe and effective in fighting kidney tu

By Zacks Investment Research
December 19, 2022

1,000% Move in a Day: Medical Stock Soars on Positive Data

IceCure Medical, a little-known medical device company surged in after-hours trading Monday. IceCure's Prosense technology proved to be a safe and eff

By Seeking Alpha
December 5, 2022

IceCure Medical Ltd (ICCM) Q3 2022 Earnings Call Transcript

IceCure Medical Ltd (NASDAQ:ICCM ) Q3 2022 Results Conference Call December 2, 2022 8:00 AM ET Company Participants Eyal Shamir - Chief Executive Offi

By InvestorPlace
November 8, 2022

What Is Going on With IceCure Medical (ICCM) Stock Today?

IceCure Medical (NASDAQ: ICCM ) stock is taking off on Tuesday as investors react to an update for Medicare coverage of breast cancer patients. The bi

By Seeking Alpha
May 18, 2022

IceCure Medical Ltd.'s (ICCM) CEO Eyal Shamir on Q1 2022 Results - Earnings Call Transcript

IceCure Medical Ltd. (NASDAQ:ICCM ) Q1 2022 Earnings Conference Call May 18, 2022 8:30 AM ET Company Participants Eyal Shamir - Chief Executive Office

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.